Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Saved in:
Bibliographic Details
Title: Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
Authors: McMillan CLD; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. c.mcmillan1@uq.edu.au., Cheung STM; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia., Modhiran N; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia., Barnes J; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Amarilla AA; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia., Bielefeldt-Ohmann H; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia.; School of Veterinary Science, The University of Queensland Gatton Campus, Gatton, QLD, 4343, Australia., Lee LYY; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia., Guilfoyle K; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands., van Amerongen G; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands., Stittelaar K; Viroclinics Xplore, Landerd Campus, Nistelrooise Baan 3, 5374 RE, Schaijk, The Netherlands., Jakob V; Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland., Lebas C; Vaccine Formulation Institute, Chemin des Aulx 14, 1228 Plan-Les-Ouates, Geneva, Switzerland., Reading P; WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, 3000, Australia.; Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Parkville, VIC, 3000, Australia., Short KR; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia., Young PR; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. p.young@uq.edu.au.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. p.young@uq.edu.au.; The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. p.young@uq.edu.au., Watterson D; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. d.watterson@uq.edu.au.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. d.watterson@uq.edu.au.; The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. d.watterson@uq.edu.au., Chappell KJ; School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD, 4072, Australia. k.chappell@uq.edu.au.; Australian Infectious Diseases Research Centre, Global Virus Network Centre of Excellence, Brisbane, QLD, 4072 and 4029, Australia. k.chappell@uq.edu.au.; The Australian Institute of Biotechnology and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia. k.chappell@uq.edu.au.
Source: NPJ vaccines [NPJ Vaccines] 2022 Jan 05; Vol. 7 (1), pp. 3. Date of Electronic Publication: 2022 Jan 05.
Publication Type: Published Erratum
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2059-0105
DOI:10.1038/s41541-021-00428-y